Clinical Trial: Phase II Study of Vandetanib in Individuals With Kidney Cancer

Sponsor and Collaborators
National Cancer Institute (NCI)

Contact
Sarah Fowler, R.N
301-435-6255

W. Marston Linehan, M.D.
301-496-6353

Principal Investigator
W. Marston Linehan, M.D.
National Cancer Institute (NCI)

ClinicalTrials.gov Identifier
NCT00566995

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs